{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:38:13Z","timestamp":1790678293525,"version":"4.1.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Rheumatoid arthritis and other autoimmune disorders are associated with altered activity of the immunomodulatory enzyme IDO. However, the precise contributions of IDO function to autoimmunity remain unclear. In this article, we examine the effect of two different IDO enzymes, IDO1 and IDO2, on the development of autoimmune arthritis in the KRN preclinical model of rheumatoid arthritis. We find that IDO2, not IDO1, is critical for arthritis development, providing direct evidence of separate in vivo functions for IDO1 and IDO2. Mice null for Ido2 display decreased joint inflammation relative to wild-type mice owing to a reduction in pathogenic autoantibodies and Ab-secreting cells. Notably, IDO2 appears to specifically mediate autoreactive responses, but not normal B cell responses, as total serum Ig levels are not altered and IDO2 knockout mice are able to mount productive Ab responses to model Ags in vitro and in vivo. Reciprocal adoptive transfer studies confirm that autoantibody production and arthritis are modulated by IDO2 expression in a cell type extrinsic to the T cell. Taken together, our results, provide important insights into IDO2 function by defining its pathogenic contributions to autoantibody-mediated autoimmunity.<\/jats:p>","DOI":"10.4049\/jimmunol.1303012","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T02:39:30Z","timestamp":1391222370000},"page":"2082-2090","source":"Crossref","is-referenced-by-count":114,"title":["IDO2 Is a Critical Mediator of Autoantibody Production and Inflammatory Pathogenesis in a Mouse Model of Autoimmune Arthritis"],"prefix":"10.1093","volume":"192","author":[{"given":"Lauren M F","family":"Merlo","sequence":"first","affiliation":[{"name":"Lankenau Institute for Medical Research , Wynnewood, PA 19096"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pigott","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research , Wynnewood, PA 19096"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"DuHadaway","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research , Wynnewood, PA 19096"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Grabler","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research , Wynnewood, PA 19096"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Metz","sequence":"additional","affiliation":[{"name":"NewLink Genetics Corp. , Ames, IA 50010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C","family":"Prendergast","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research , Wynnewood, PA 19096"},{"name":"Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University , Philadelphia, PA 19107"},{"name":"Kimmel Cancer Center, Thomas Jefferson University , Philadelphia, PA 19107"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mandik-Nayak","sequence":"additional","affiliation":[{"name":"Lankenau Institute for Medical Research , Wynnewood, PA 19096"},{"name":"Department of Microbiology and Immunology, Thomas Jefferson University , Philadelphia, PA 19107"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,3,1]]},"reference":[{"key":"2025032404154657000_r1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1600-065X.2010.00945.x","article-title":"B-cell targeted therapies in human autoimmune diseases: an updated perspective","volume":"237","author":"Townsend","year":"2010","journal-title":"Immunol. Rev."},{"key":"2025032404154657000_r2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40259-013-0015-8","article-title":"B-cell targeted therapies in systemic lupus erythematosus: successes and challenges","volume":"27","author":"Harvey","year":"2013","journal-title":"BioDrugs"},{"key":"2025032404154657000_r3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"2025032404154657000_r4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2025032404154657000_r5","doi-asserted-by":"crossref","first-page":"vi28","DOI":"10.1093\/rheumatology\/kes278","article-title":"Evolution of treatment for rheumatoid arthritis","volume":"51","author":"Upchurch","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2025032404154657000_r6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3181\/00379727-117-29689","article-title":"Tryptophan metabolite excretion in connective tissue diseases demonstrating a difference between rheumatoid spondylitis and rheumatoid arthritis","volume":"117","author":"Beetham","year":"1964","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"2025032404154657000_r7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/17.4.227","article-title":"Metabolic abnormalities of tryptophan and nicotinic acid in patients with rheumatoid arthritis","volume":"17","author":"Labadarios","year":"1978","journal-title":"Rheumatol. Rehabil."},{"key":"2025032404154657000_r8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archderm.1966.01600270108023","article-title":"Tryptophan metabolism. Results of studies in discoid lupus erythematosus","volume":"94","author":"Mandel","year":"1966","journal-title":"Arch. Dermatol."},{"key":"2025032404154657000_r9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1172\/JCI106043","article-title":"Serum kynurenine in rheumatoid arthritis","volume":"48","author":"Spiera","year":"1969","journal-title":"J. Clin. Invest."},{"key":"2025032404154657000_r10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-1-4615-4709-9_71","article-title":"Degradation of tryptophan in patients with systemic lupus erythematosus","volume":"467","author":"Widner","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"2025032404154657000_r11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0171-2985(00)80079-0","article-title":"Enhanced tryptophan degradation in systemic lupus erythematosus","volume":"201","author":"Widner","year":"2000","journal-title":"Immunobiology"},{"key":"2025032404154657000_r12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2362.2011.02491.x","article-title":"Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study","volume":"41","author":"Furuzawa-Carballeda","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"2025032404154657000_r13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.2007.03480.x","article-title":"Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season","volume":"150","author":"Pertovaara","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"2025032404154657000_r14","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Munn","year":"1998","journal-title":"Science"},{"key":"2025032404154657000_r15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/PSY.0b013e318266d0f5","article-title":"Indoleamine 2,3-dioxygenase activation and depressive symptoms: results from the Young Finns Study","volume":"74","author":"Elovainio","year":"2012","journal-title":"Psychosom. Med."},{"key":"2025032404154657000_r16","first-page":"56","article-title":"Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later","volume":"47","author":"Oxenkrug","year":"2010","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"2025032404154657000_r17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1164\/rccm.201304-0700OC","article-title":"Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension","volume":"188","author":"Xiao","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025032404154657000_r18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc1929","article-title":"Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors","volume":"6","author":"Muller","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"2025032404154657000_r19","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2174\/092986711795656072","article-title":"Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases","volume":"18","author":"Prendergast","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"2025032404154657000_r20","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2003.08.031","article-title":"Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice","volume":"125","author":"Gurtner","year":"2003","journal-title":"Gastroenterology"},{"key":"2025032404154657000_r21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0165-5728(02)00176-5","article-title":"Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis","volume":"129","author":"Sakurai","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"2025032404154657000_r22","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar2205","article-title":"Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice","volume":"9","author":"Sz\u00e1nt\u00f3","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"2025032404154657000_r23","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.4049\/jimmunol.0804328","article-title":"The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity","volume":"182","author":"Scott","year":"2009","journal-title":"J. Immunol."},{"key":"2025032404154657000_r24","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1073\/pnas.0708809105","article-title":"Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation","volume":"105","author":"Xu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032404154657000_r25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1398-9995.2012.02830.x","article-title":"The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy","volume":"67","author":"von Bubnoff","year":"2012","journal-title":"Allergy"},{"key":"2025032404154657000_r26","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxt073","article-title":"IDO2 is critical for IDO1-mediated T cell regulation and exerts a non-redundant function in inflammation","volume-title":"Int. Immunol.","author":"Metz","year":"2014"},{"key":"2025032404154657000_r27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","article-title":"Organ-specific disease provoked by systemic autoimmunity","volume":"87","author":"Kouskoff","year":"1996","journal-title":"Cell"},{"key":"2025032404154657000_r28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","article-title":"From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins","volume":"10","author":"Korganow","year":"1999","journal-title":"Immunity"},{"key":"2025032404154657000_r29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.286.5445.1732","article-title":"Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme","volume":"286","author":"Matsumoto","year":"1999","journal-title":"Science"},{"key":"2025032404154657000_r30","doi-asserted-by":"crossref","first-page":"14368","DOI":"10.1073\/pnas.182549099","article-title":"Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node","volume":"99","author":"Mandik-Nayak","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032404154657000_r31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biopha.2006.09.002","article-title":"Autoantibodies in rheumatoid arthritis: a review","volume":"60","author":"Mewar","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"2025032404154657000_r32","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/art.34406","article-title":"Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K\/BxN mice","volume":"64","author":"Pigott","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2025032404154657000_r33","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/onci.21716","article-title":"IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: a novel IDO effector pathway targeted by D-1-methyl-tryptophan","volume":"1","author":"Metz","year":"2012","journal-title":"OncoImmunology"},{"key":"2025032404154657000_r34","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","article-title":"Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan","volume":"67","author":"Metz","year":"2007","journal-title":"Cancer Res."},{"key":"2025032404154657000_r35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jri.2003.11.003","article-title":"Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific","volume":"61","author":"Baban","year":"2004","journal-title":"J. Reprod. Immunol."},{"key":"2025032404154657000_r36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1570-0232(02)00572-X","article-title":"Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"780","author":"Amirkhani","year":"2002","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"2025032404154657000_r37","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.173.5.1165","article-title":"In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations","volume":"173","author":"Jacob","year":"1991","journal-title":"J. Exp. Med."},{"key":"2025032404154657000_r38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gene.2007.04.010","article-title":"Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice","volume":"396","author":"Ball","year":"2007","journal-title":"Gene"},{"key":"2025032404154657000_r39","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00262-012-1265-x","article-title":"Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation","volume":"61","author":"Qian","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"2025032404154657000_r40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00239-007-9049-1","article-title":"Evolution of vertebrate indoleamine 2,3-dioxygenases","volume":"65","author":"Yuasa","year":"2007","journal-title":"J. Mol. Evol."},{"key":"2025032404154657000_r41","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-06-2925","article-title":"Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses","volume":"67","author":"Hou","year":"2007","journal-title":"Cancer Res."},{"key":"2025032404154657000_r42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.194.3.321","article-title":"Genetic influences on the end-stage effector phase of arthritis","volume":"194","author":"Ji","year":"2001","journal-title":"J. Exp. Med."},{"key":"2025032404154657000_r43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1385\/IR:32:1-3:005","article-title":"Initiation of an autoimmune response: insights from a transgenic model of rheumatoid arthritis","volume":"32","author":"Mandik-Nayak","year":"2005","journal-title":"Immunol. Res."},{"key":"2025032404154657000_r44","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.4049\/jimmunol.1301173","article-title":"The cellular source and target of IL-21 in K\/BxN autoimmune arthritis","volume":"191","author":"Block","year":"2013","journal-title":"J. Immunol."},{"key":"2025032404154657000_r45","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/art.21104","article-title":"Interleukin-4 can be a key positive regulator of inflammatory arthritis","volume":"52","author":"Ohmura","year":"2005","journal-title":"Arthritis Rheum."},{"key":"2025032404154657000_r46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1084\/jem.20020439","article-title":"Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis","volume":"196","author":"Ji","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025032404154657000_r47","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","article-title":"Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum."},{"key":"2025032404154657000_r48","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/annrheumdis-2012-202470","article-title":"Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement","volume":"72","author":"Schoels","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"2025032404154657000_r49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaut.2010.10.007","article-title":"Th17 cells can provide B cell help in autoantibody induced arthritis","volume":"36","author":"Hickman-Brecks","year":"2011","journal-title":"J. Autoimmun."},{"key":"2025032404154657000_r50","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2353\/ajpath.2010.100195","article-title":"Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K\/BxN mouse","volume":"177","author":"LaBranche","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2025032404154657000_r51","doi-asserted-by":"crossref","first-page":"17073","DOI":"10.1073\/pnas.0806173105","article-title":"Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase","volume":"105","author":"Muller","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032404154657000_r52","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/01.tp.0000263991.74052.46","article-title":"Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts","volume":"83","author":"Yang","year":"2007","journal-title":"Transplantation"},{"key":"2025032404154657000_r53","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-12-0014","article-title":"IDO is a nodal pathogenic driver of lung cancer and metastasis development","volume":"2","author":"Smith","year":"2012","journal-title":"Cancer Discov."},{"key":"2025032404154657000_r54","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bbapap.2011.07.023","article-title":"Purification and kinetic characterization of human indoleamine 2,3-dioxygenases 1 and 2 (IDO1 and IDO2) and discovery of selective IDO1 inhibitors","volume":"1814","author":"Meininger","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"2025032404154657000_r55","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1369\/0022155412458926","article-title":"Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis","volume":"60","author":"Fukunaga","year":"2012","journal-title":"J. Histochem. Cytochem."},{"key":"2025032404154657000_r56","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/art.24446","article-title":"Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1\/Th17 cells in the joint in collagen-induced arthritis","volume":"60","author":"Criado","year":"2009","journal-title":"Arthritis Rheum."},{"key":"2025032404154657000_r57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbpb.2010.04.006","article-title":"1-L-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-D-methyltryptophan","volume":"157","author":"Yuasa","year":"2010","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"2025032404154657000_r58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"2025032404154657000_r59","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.4049\/jimmunol.0804350","article-title":"A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25\u2212 T cell expansion is essential for the development of arthritis in autoimmune K\/BxN mice","volume":"182","author":"Jang","year":"2009","journal-title":"J. Immunol."},{"key":"2025032404154657000_r60","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","article-title":"Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells","volume":"32","author":"Wu","year":"2010","journal-title":"Immunity"},{"key":"2025032404154657000_r61","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/08820139.2012.676122","article-title":"Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity","volume":"41","author":"Harden","year":"2012","journal-title":"Immunol. Invest."},{"key":"2025032404154657000_r62","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ni.2019","article-title":"Germinal center B and follicular helper T cells: siblings, cousins or just good friends?","volume":"12","author":"Nutt","year":"2011","journal-title":"Nat. Immunol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/192\/5\/2082\/62517791\/1303012.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/192\/5\/2082\/62517791\/1303012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T06:31:08Z","timestamp":1742797868000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/192\/5\/2082\/7993453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,1]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1303012","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,3]]},"published":{"date-parts":[[2014,3,1]]}}}